112 related articles for article (PubMed ID: 12777209)
21. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS
Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296
[TBL] [Abstract][Full Text] [Related]
22. Characterization of subepithelial interstitial cells in normal and pathological human prostate.
Gevaert T; Lerut E; Joniau S; Franken J; Roskams T; De Ridder D
Histopathology; 2014 Sep; 65(3):418-28. PubMed ID: 24571575
[TBL] [Abstract][Full Text] [Related]
23. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry.
Ehara H; Koji T; Deguchi T; Yoshii A; Nakano M; Nakane PK; Kawada Y
Prostate; 1995 Dec; 27(6):304-13. PubMed ID: 7501542
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic factor, but not oxytocin, is present in atherosclerotic plaques of human common carotid arteries.
La Barbera G; La Marca G; Valentino F; Lipari D; Peri G; Cappello F; Valentino B
Ital J Anat Embryol; 2009; 114(2-3):129-36. PubMed ID: 20198825
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2000 Jul; 157(1):249-55. PubMed ID: 10880394
[TBL] [Abstract][Full Text] [Related]
26. Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance.
Albrecht M; Renneberg H; Wennemuth G; Möschler O; Janssen M; Aumüller G; Konrad L
Histochem Cell Biol; 1999 Jul; 112(1):51-61. PubMed ID: 10461812
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
29. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
[TBL] [Abstract][Full Text] [Related]
30. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
31. Zonal differences in prostate diseases.
Jiang Q; Xia SJ
Chin Med J (Engl); 2012 May; 125(9):1523-8. PubMed ID: 22800815
[No Abstract] [Full Text] [Related]
32. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
33. [Stromal cells inhibit Kallikrein 7 expression in the epithelial cells of benign prostate hyperplasia].
Yang XL; Xuan Q; Huang FY; Pang YH; Mo ZN
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):305-9. PubMed ID: 21548205
[TBL] [Abstract][Full Text] [Related]
34. Stimulative effect of transforming growth factor-beta on collagen synthesis by human prostatic stromal cells in vitro.
Fukabori Y; Nakano K; Ohyama A; Yamanaka H
Int J Urol; 1997 Nov; 4(6):597-602. PubMed ID: 9477191
[TBL] [Abstract][Full Text] [Related]
35. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.
Jia X; Sun Y; Wang B
IUBMB Life; 2014 Dec; 66(12):847-53. PubMed ID: 25631296
[TBL] [Abstract][Full Text] [Related]
36. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
Turhan OI; Aydin NE; Sariyüce O; Ozkan S
Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal transition in prostatic disease.
Broster SA; Kyprianou N
Future Oncol; 2015; 11(23):3197-206. PubMed ID: 26551285
[TBL] [Abstract][Full Text] [Related]
38. Normal histology of the prostate.
McNeal JE
Am J Surg Pathol; 1988 Aug; 12(8):619-33. PubMed ID: 2456702
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical and biomolecular identification of orphanin FQ, eNOS, atrial natriuretic factor and oxytocin in rat seminal vesicles.
Mauro A; Buscemi M; Cappello F; Uzzo ML; Farina-Lipari E; Martorana A; Gerbino A
Anat Histol Embryol; 2009 Nov; 38(6):443-8. PubMed ID: 19754859
[TBL] [Abstract][Full Text] [Related]
40. Biosynthesis and localization of inhibin in human prostate.
Sathe VS; Sheth NA; Phadke MA; Sheth AR; Zaveri JP
Prostate; 1987; 10(1):33-43. PubMed ID: 2434935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
